INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 41m ago
HOUSE PTR38s ago
SEC 13F30s ago
ROBINHOOD CHAIN26s ago
PJ
Corporate insider

Pitofsky Jason

SVP ControllerCIK 0002009236

EDGAR filingsOpen in network
Disclosed transactions31
Buys / sells0 / 20
Max Insider Score36
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
—
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M$1.09M
1,500 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    REGENERON PHARMACEUTICALS, INC.VP Controller · Nov 10, 2025
—
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M
$953K
1,478 sh
Nov 4, 2026
Nov 6, 2026
traded Nov 4, 2026
+2d
SEC FORM 4

Evidence

—
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M$445K
905 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

—
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$412K
439 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

—
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$541K
575 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

—
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$925K
982 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

—
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$1.14M
1,215 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

—
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$499K
529 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

—
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$102K
108 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

—
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$33K
35 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

—
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$170K
179 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

—
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M—
905 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

—
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M—
1,478 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

—
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M—
1,500 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC FORM 4

Evidence

4
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$59K
75 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC FORM 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$785
1 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC FORM 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$16K
20 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC FORM 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$20K
26 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC FORM 4

Evidence

11
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$405K
521 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC FORM 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$29K
37 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC FORM 4

Evidence

4
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$113K
144 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC FORM 4

Evidence

5
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M$492K
1,000 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC FORM 4

Evidence

11
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$304K
391 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC FORM 4

Evidence

11
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$438K
563 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC FORM 4

Evidence

4
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$160K
205 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC FORM 4

Evidence

0
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M—
1,000 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC FORM 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$42K
53 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC FORM 4

Evidence

5
PJ
Pitofsky JasonVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Grant or award
A—
2,261 sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence

19
PJ
Pitofsky JasonVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Tax withholding
F$705K
989 sh
Dec 8, 2025Dec 9, 2025
traded Dec 8, 2025
+1dSEC FORM 4

Evidence

13
PJ
Pitofsky JasonVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Grant or award
A—
2,064 sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence

36
PJ
Pitofsky JasonVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$281K
431 sh
Nov 7, 2025Nov 10, 2025
traded Nov 7, 2025
+3dSEC FORM 4

Evidence